The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type - Implications for the role of amyloid-beta 1-42 in Alzheimer's disease

被引:83
|
作者
Castano, EM
Prelli, F
Soto, C
Beavis, R
Matsubara, E
Shoji, M
Frangione, B
机构
[1] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10016
[2] NYU,MED CTR,DEPT PHARMACOL,NEW YORK,NY 10016
[3] GUNMA UNIV,SCH MED,DEPT NEUROL,GUNMA 371,JAPAN
关键词
D O I
10.1074/jbc.271.50.32185
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCEFWA-D), a genetic variant (E22Q) of amyloid beta (A beta) accumulates predominantly in the small vessels of leptomeninges and cerebral cortex, leading to fatal strokes in the fifth or sixth decade of life, A beta deposition in the neuropil occurs mainly in the form of preamyloid, Congo red negative deposits, while mature neuritic plaques and neurofibrillary tangles, hallmark lesions in Alzheimer's disease (AD), are characteristically absent, A recent hypothesis regarding the patho genesis of AD states that A beta extending to residues 42-43 (as opposed to shorter species) can seed amyloid formation and trigger the development of neuritic plaques followed by neuronal damage in AD. We characterized biochemically and immunohistochemically A beta from three cases of HCHWA-D to determine its length in vascular and parenchymal deposits, Mass spectrometry of formic acid-soluble amyloid, purified by size-exclusion gel chromatography, showed that A beta 1-40 and its carboxyl-terminal truncated derivatives were the predominant forms in leptomeningeal and cortical vessels, A beta 1-42 was a minor component in these amyloid extracts, Immunohistochemistry with antibodies S40 and S42, specific for A beta ending at Val-40 or Ala-42, respectively, were consistent with the biochemical data from vascular amyloid. In addition, parenchymal preamyloid lesions were specifically stained with S42 and were not labeled by S40, in agreement with the pattern reported for AD, Down's syndrome, and aged dogs, Our results suggest that in HCHWA-D the carboxyl-terminal A beta heterogeneity is due to limited proteolysis in vivo, Moreover, they suggest that A beta species ending at Ala-42 may not be critical for the seeding of amyloid formation and the development of AD-like neuritic changes.
引用
收藏
页码:32185 / 32191
页数:7
相关论文
共 50 条
  • [1] AMYLOID-BETA PROTEIN-PRECURSOR GENE AND HEREDITARY CEREBRAL-HEMORRHAGE WITH AMYLOIDOSIS (DUTCH)
    VAN BROECKHOVEN, C
    HAAN, J
    BAKKER, E
    HARDY, JA
    VANHUL, W
    WEHNERT, A
    VEGTERVANDERVLIS, M
    ROOS, RAC
    SCIENCE, 1990, 248 (4959) : 1120 - 1122
  • [2] Amyloid-beta and Alzheimer's disease: the role of neprilysin-2 in amyloid-beta clearance
    Marr, Robert A.
    Hafez, Daniel M.
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
  • [3] Extracellular matrix modulator lysyl oxidase colocalizes with amyloid-beta pathology in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type
    Wilhelmus, Micha M. M.
    Bol, John G. J. M.
    van Duinen, Sjoerd G.
    Drukarch, Benjamin
    EXPERIMENTAL GERONTOLOGY, 2013, 48 (02) : 109 - 114
  • [4] UBIQUITINATED NEURITES ARE ASSOCIATED WITH PREAMYLOID AND CEREBRAL AMYLOID-BETA DEPOSITS IN PATIENTS WITH HEREDITARY CEREBRAL-HEMORRHAGE WITH AMYLOIDOSIS DUTCH TYPE
    TAGLIAVINI, F
    GIACCONE, G
    BUGIANI, O
    FRANGIONE, B
    ACTA NEUROPATHOLOGICA, 1993, 85 (03) : 267 - 271
  • [5] Presenilins, amyloid-beta and Alzheimer's disease
    Lamb, BT
    NATURE MEDICINE, 1997, 3 (01) : 28 - 29
  • [6] Full-length amyloid-beta(1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques
    Iwatsubo, T
    Saido, TC
    Mann, DMA
    Lee, VMY
    Trojanowski, JQ
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (06): : 1823 - 1830
  • [7] Predominant deposition of amyloid-beta(42(43)) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene
    Mann, DMA
    Iwatsubo, T
    Ihara, Y
    Cairns, NJ
    Lantos, PL
    Bogdanovic, N
    Lannfelt, L
    Winblad, B
    MaatSchieman, MLC
    Rossor, MN
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 148 (04): : 1257 - 1266
  • [8] AMYLOID-BETA AMYLOIDOSIS IN ALZHEIMERS-DISEASE
    PRICE, DL
    SISODIA, SS
    GANDY, SE
    CURRENT OPINION IN NEUROLOGY, 1995, 8 (04) : 268 - 274
  • [9] Amyloid-beta antibody treatment in Alzheimer's disease
    Stoegmann, Elisabeth
    Schmidt, Reinhold
    WIENER KLINISCHE WOCHENSCHRIFT, 2024,
  • [10] Plasma and cerebrospinal fluid concentrations of amyloid-beta 1-42 in the diagnosis of Alzheimer's disease and vascular dementia
    Arlt, S
    Dellbrügger, E
    Beisiegel, U
    Ganzer, S
    Müller-Thomsen, T
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S385 - S385